These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27308511)

  • 1. The ubiquitin-proteasome system and activation of NF-κB: involvement of the ubiquitin ligase KPC1 in p105 processing and tumor suppression.
    Kravtsova-Ivantsiv Y; Ciechanover A
    Mol Cell Oncol; 2015; 2(4):e1054552. PubMed ID: 27308511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC.
    Goldhirsh G; Kravtsova-Ivantsiv Y; Satish G; Ziv T; Brik A; Ciechanover A
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth.
    Kravtsova-Ivantsiv Y; Shomer I; Cohen-Kaplan V; Snijder B; Superti-Furga G; Gonen H; Sommer T; Ziv T; Admon A; Naroditsky I; Jbara M; Brik A; Pikarsky E; Kwon YT; Doweck I; Ciechanover A
    Cell; 2015 Apr; 161(2):333-47. PubMed ID: 25860612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NF-ĸB p50 subunit generated by KPC1-mediated ubiquitination and limited proteasomal processing, suppresses tumor growth.
    Kravtsova-Ivantsiv Y; Goldhirsh G; Tomuleasa C; Pikarsky E; Ciechanover A
    Cancer Cell Int; 2023 Apr; 23(1):67. PubMed ID: 37055826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation.
    Udasin RG; Gottfried Y; Fabre B; Bercovich B; Ziv T; Ciechanover A
    Biochem Biophys Res Commun; 2021 Jun; 558():224-230. PubMed ID: 32933748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A20 inhibits both the degradation and limited processing of the NF-κB p105 precursor: A novel additional layer to its regulator role.
    Lapid D; Lahav-Baratz S; Cohen S
    Biochem Biophys Res Commun; 2017 Nov; 493(1):52-57. PubMed ID: 28923245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tumor Suppressor Functions of Ubiquitin Ligase KPC1: From Cell-Cycle Control to NF-κB Regulator.
    Gulei D; Drula R; Ghiaur G; Buzoianu AD; Kravtsova-Ivantsiv Y; Tomuleasa C; Ciechanover A
    Cancer Res; 2023 Jun; 83(11):1762-1767. PubMed ID: 36880841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess of the NF-ĸB p50 subunit generated by the ubiquitin ligase KPC1 suppresses tumors via PD-L1- and chemokines-mediated mechanisms.
    Kravtsova-Ivantsiv Y; Goldhirsh G; Ivantsiv A; Ben Itzhak O; Kwon YT; Pikarsky E; Ciechanover A
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29823-29831. PubMed ID: 33168738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The A-to-I editing of KPC1 promotes intrahepatic cholangiocarcinoma by attenuating proteasomal processing of NF-κB1 p105 to p50.
    Gao C; Zhou G; Shi J; Shi P; Jin L; Li Y; Wang X; Liao S; Yan H; Wu J; Lu Y; Zhai Y; Zhang J; Zhang H; Zhang H; Yang C; Cao P; Cheng S; Zhou G
    J Exp Clin Cancer Res; 2022 Dec; 41(1):338. PubMed ID: 36476255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFKB1: a suppressor of inflammation, ageing and cancer.
    Cartwright T; Perkins ND; L Wilson C
    FEBS J; 2016 May; 283(10):1812-22. PubMed ID: 26663363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.
    Iida Y; Ciechanover A; Marzese DM; Hata K; Bustos M; Ono S; Wang J; Salomon MP; Tran K; Lam S; Hsu S; Nelson N; Kravtsova-Ivantsiv Y; Mills GB; Davies MA; Hoon DSB
    Clin Cancer Res; 2017 Aug; 23(16):4831-4842. PubMed ID: 28389511
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain.
    Orian A; Schwartz AL; Israël A; Whiteside S; Kahana C; Ciechanover A
    Mol Cell Biol; 1999 May; 19(5):3664-73. PubMed ID: 10207090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary study on the inhibitory effect of tumor suppressor gene KPC1 on the proliferation in gastric carcinoma cell.
    Zhou M; Qu CY; Ding WJ; Cai XL; Shen YJ; Chen YW; Xu LM
    Ann Transl Med; 2020 Mar; 8(6):343. PubMed ID: 32355787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105.
    Ciechanover A; Gonen H; Bercovich B; Cohen S; Fajerman I; Israël A; Mercurio F; Kahana C; Schwartz AL; Iwai K; Orian A
    Biochimie; 2001; 83(3-4):341-9. PubMed ID: 11295495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor.
    Kravtsova-Ivantsiv Y; Cohen S; Ciechanover A
    Mol Cell; 2009 Feb; 33(4):496-504. PubMed ID: 19250910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin ligase TRUSS augments the expression of interleukin-10 via proteasomal processing of NF-κB1/p105 to NF-κB/p50.
    Jamal A; Husein A; Bihari C; Kumar V
    Cell Signal; 2020 Nov; 75():109766. PubMed ID: 32889079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of p105 is inhibited by docking of p50 active subunits to the ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ ubiquitin-ligase binding domain.
    Cohen S; Orian A; Ciechanover A
    J Biol Chem; 2001 Jul; 276(29):26769-76. PubMed ID: 11350967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism.
    Guégan JP; Pollet J; Ginestier C; Charafe-Jauffret E; Peter ME; Legembre P
    iScience; 2021 Dec; 24(12):103538. PubMed ID: 34917906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.
    Heissmeyer V; Krappmann D; Hatada EN; Scheidereit C
    Mol Cell Biol; 2001 Feb; 21(4):1024-35. PubMed ID: 11158290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
    Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C
    EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.